Your browser doesn't support javascript.
loading
Dissection of CD20 regulation in lymphoma using RNAi.
Slabicki, M; Lee, K S; Jethwa, A; Sellner, L; Sacco, F; Walther, T; Hüllein, J; Dietrich, S; Wu, B; Lipka, D B; Oakes, C C; Mamidi, S; Pyrzynska, B; Winiarska, M; Oles, M; Seifert, M; Plass, C; Kirschfink, M; Boettcher, M; Golab, J; Huber, W; Fröhling, S; Zenz, T.
Afiliação
  • Slabicki M; Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Lee KS; Department of Molecular Therapy in Haematology and Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Jethwa A; Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sellner L; Department of Molecular Therapy in Haematology and Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sacco F; Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Walther T; Department of Molecular Therapy in Haematology and Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hüllein J; Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Dietrich S; Department of Molecular Therapy in Haematology and Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Wu B; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Lipka DB; Department of Proteomics and Signal Transduction, Max-Planck Institute for Biochemistry, Martinsried, Germany.
  • Oakes CC; Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Mamidi S; Department of Molecular Therapy in Haematology and Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Pyrzynska B; Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Winiarska M; Department of Molecular Therapy in Haematology and Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Oles M; Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Seifert M; Department of Molecular Therapy in Haematology and Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Plass C; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Kirschfink M; Department of Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
  • Boettcher M; Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Golab J; Department of Molecular Therapy in Haematology and Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Huber W; Department of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Fröhling S; Department of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Zenz T; Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA.
Leukemia ; 30(12): 2409-2412, 2016 12.
Article em En | MEDLINE | ID: mdl-27560109
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos CD20 / Interferência de RNA / Linfoma Limite: Humans Idioma: En Revista: Leukemia Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos CD20 / Interferência de RNA / Linfoma Limite: Humans Idioma: En Revista: Leukemia Ano de publicação: 2016 Tipo de documento: Article